Royal Society of Chemistry, Biomaterials Science, 5(11), p. 1704-1713, 2023
DOI: 10.1039/d2bm01836e
Full text: Unavailable
Polymer microneedle patches for transdermal delivery of anti-hyperuricemia drugs (Allopurinol, AP) have been developed for regulating serum uric acid levels, reducing adverse reactions and improving the bioavailability of AP.